Novolog (Pharm-Up 1966) Cash Flow Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	4.12	39.54	-42	47.51	42.32
Depreciation & Amortization	57.67	57.18	103.98	44.55	38.48
Other Amortization	19.26	9.9	-	-	-
Loss (Gain) From Sale of Assets	-0.16	-0.13	0.14	-0.34	-0.53
Loss (Gain) on Equity Investments	-1.26	0.44	30.64	4.61	1.64
Stock-Based Compensation	3.7	3.2	-0.16	2.35	2.58
Other Operating Activities	-6.83	15.07	0.67	15.84	15.47
Change in Accounts Receivable	717.17	-188.74	-242.32	-7.35	-14.65
Change in Inventory	59.91	-67.97	-57.43	-2.16	69.51
Change in Accounts Payable	-868.59	277.86	418.31	41.17	-60.47
Change in Income Taxes	-2.53	1.35	-5.63	-11.08	-3.85
Change in Other Net Operating Assets	16.82	10.83	-6.19	-2.45	-7.11
Operating Cash Flow	-0.73	158.52	200.01	132.65	83.39
Operating Cash Flow Growth	-	-20.75%	50.79%	59.08%	42.58%
Capital Expenditures	-17.72	-13.39	-36.25	-44.97	-30.64
Sale of Property, Plant & Equipment	0.31	0.31	0.18	0.97	2.52
Cash Acquisitions	-	-	-9.71	-50.9	-19.02
Sale (Purchase) of Intangibles	-44.84	-45.34	-34.71	-24.52	-
Investment in Securities	-	-	-3.1	-11.93	-26.71
Other Investing Activities	5.8	10.13	10.98	6.41	4.78
Investing Cash Flow	-56.44	-50.55	-72.6	-124.95	-69.07
Short-Term Debt Repaid	-	-	-0.07	-	-
Long-Term Debt Repaid	-26.02	-26.94	-23.54	-18.79	-28.97
Total Debt Repaid	-26.02	-26.94	-23.61	-18.79	-28.97
Net Debt Issued (Repaid)	-26.02	-26.94	-23.61	-18.79	-28.97
Issuance of Common Stock	-	-	-	-	119.83
Common Dividends Paid	-20	-40	-16.9	-31.9	-32
Other Financing Activities	-21.25	-27.65	-27.2	-22.27	-11.37
Financing Cash Flow	-67.27	-94.59	-67.71	-72.96	47.49
Foreign Exchange Rate Adjustments	3.54	1.28	0.44	-0.64	0.46
Miscellaneous Cash Flow Adjustments	-4.94	-	-	-	-
Net Cash Flow	-125.83	14.66	60.13	-65.9	62.27
Free Cash Flow	-18.45	145.12	163.77	87.68	52.75
Free Cash Flow Growth	-	-11.38%	86.79%	66.21%	60.48%
Free Cash Flow Margin	-1.02%	7.18%	9.96%	5.81%	4.20%
Free Cash Flow Per Share	-0.04	0.28	0.32	0.17	0.10
Cash Interest Paid	18	11.42	11.25	11.44	7.62
Cash Income Tax Paid	22.97	18.3	22.07	33.8	19
Levered Free Cash Flow	-69.78	85.03	156.96	38.37	27.94
Unlevered Free Cash Flow	-57.74	92.91	165	46.2	33.23
Change in Working Capital	-77.23	33.32	106.74	18.13	-16.57

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.